Frozen shoulder and menopause: why might they be connected?

What researchers know, what remains uncertain, and when to seek evaluation

Older woman raising her arms during a gentle stretch in a park
Quick answer

Frozen shoulder causes progressive shoulder pain and stiffness, and it often appears during the same midlife years as the menopause transition. Researchers are studying hormonal, metabolic, and inflammatory explanations for that overlap. Current evidence shows a possible association, not a proven cause, and it does not establish hormone therapy as a frozen-shoulder treatment.

This article is general education, not a diagnosis or treatment plan. New or worsening shoulder symptoms require individual evaluation. Do not start, stop, or change hormone therapy based on shoulder symptoms without guidance from a licensed clinician.

What frozen shoulder is

Frozen shoulder is also called adhesive capsulitis. It develops when the tissues around the shoulder joint become painful and stiff, limiting both active movement and movement assisted by another person.

The American Academy of Orthopaedic Surgeons describes pain and progressive loss of shoulder motion as central features. Other shoulder problems can produce pain or limited movement, so symptoms alone cannot confirm adhesive capsulitis.

Woman stretching one arm across her chest during a home workout
An at-home arm stretch shown for general movement context; no diagnosis or treatment recommendation is implied.

Why the menopause connection gets attention

Frozen shoulder commonly affects adults in midlife, and women are frequently represented among patients. That timing overlaps with perimenopause and menopause for many people. Online discussions often turn that overlap into a causal claim before the research can support one.

Optimize's perimenopause symptom guide covers the broader transition. A new shoulder problem still needs its own assessment because tendon, joint, nerve, thyroid, metabolic, injury, and other factors may enter the picture.

What current research suggests

A 2025 peer-reviewed narrative review discusses frozen shoulder within a wider endocrine, metabolic, vascular, and immune framework. It examines how estrogen signaling might interact with inflammation and fibrosis. A narrative review organizes existing evidence and hypotheses; it cannot prove that menopause caused an individual's condition.

A 2026 preliminary pilot study was designed to explore whether hormone therapy might be associated with adhesive capsulitis risk in menopausal women. The study's early design and association question are useful for future research. They do not establish prevention or treatment guidance.

What the evidence cannot prove

Current research does not justify several common conclusions:

  • Menopause is the cause of every frozen shoulder case
  • A low estrogen level confirms the source of shoulder pain
  • Hormone therapy prevents adhesive capsulitis
  • Starting or changing hormone therapy will restore shoulder movement
  • Shoulder symptoms can be evaluated without considering other conditions

Research findings apply to groups. A clinical decision applies to a person with a particular history, examination, risk profile, and goals.

Other factors clinicians may consider

Frozen shoulder can occur without a clear trigger. It may also appear after shoulder injury, surgery, or a period of limited movement. Diabetes and thyroid disorders are frequently discussed in clinical reviews of adhesive capsulitis. Age, previous shoulder disease, and other health factors may affect the assessment.

That list should not become a self-diagnosis checklist. It helps explain why a clinician may ask about movement, onset, medical conditions, medicines, prior injury, and previous treatment.

Where menopause care may fit

Menopause care may be relevant when hot flashes, sleep disruption, vaginal symptoms, cycle changes, or other concerns are present alongside the shoulder complaint. Those symptoms can be reviewed on their own merits.

The American College of Obstetricians and Gynecologists explains that hormone-therapy decisions depend on symptoms, personal and family health history, risks, and continuing reassessment. Frozen shoulder is not established there as an indication for hormone therapy.

Doctor and patient talking across a desk in a bright clinic
A routine clinical conversation; no condition is attributed to the people shown, and they are not presented as an Optimize 360 patient or clinician.

Optimize 360 offers women's health evaluation for menopause-related concerns. A shoulder specialist or other qualified clinician may be needed to evaluate a marked loss of motion. Coordination matters when both concerns are active.

When to seek shoulder evaluation

Arrange an evaluation if shoulder pain persists, movement is getting more restricted, sleep is disrupted by pain, or ordinary tasks such as reaching a shelf or fastening clothing become difficult. Seek prompt care after significant trauma, visible deformity, sudden weakness, fever, chest symptoms, or other urgent changes.

Bring a short record of:

  • When the pain and stiffness began
  • Which movements are limited
  • Any injury, surgery, or period of immobilization
  • Current medicines and medical conditions
  • Menopause symptoms and any current hormone therapy

That history helps clinicians separate a shoulder diagnosis from a menopause treatment decision while still considering how the two may interact.

Sources

TESTIMONIALS | PATIENT REVIEWS

What Our Patients Say